AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

The two Victorian H7 strains of avian influenza have been successfully eradicated, but some farmers fear more frequent ...

A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Wrexham are poised to beat a number of Championship and European clubs to the signature of Reading forward Sam Smith, ...

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

If the Rams are looking to free up cap space, these 6 players could be on the chopping block – including Cooper Kupp ...

Earleen Fisher, an editor and writer whose career across five decades with The Associated Press gave her a front-row seat to ...

Bajaj Healthcare has received approval from India's Drug Controller General to manufacture Pimavanserin, a drug for Parkinson's-related hallucinations and delusions. Pimavanserin, already popular in ...